{
  "success": true,
  "pagesUsed": [
    1,
    2,
    3,
    6,
    7,
    8,
    9,
    10,
    14,
    15,
    16,
    17,
    18,
    19,
    25,
    26,
    27,
    28,
    29,
    34,
    35,
    36,
    37,
    38,
    39,
    40,
    41,
    42,
    43,
    44,
    45,
    48,
    49
  ],
  "modelUsed": "gemini-3-flash-preview",
  "interventions": {
    "studyInterventions": [
      {
        "id": "int_1",
        "name": "Pembrolizumab (MK-3475)",
        "type": {
          "id": "bd304fbd-c46c-46e5-b1e4-31f5f8ca73a6",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "f7cc3921-7ecf-451c-95b0-51d26aea7472",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Anti-PD-1 monoclonal antibody for advanced/metastatic esophageal cancer",
        "productIds": [
          "prod_1"
        ],
        "administrationIds": [
          "admin_1"
        ]
      },
      {
        "id": "int_2",
        "name": "Paclitaxel",
        "type": {
          "id": "752de108-7ba3-4af8-8adf-f35f4cb57c4e",
          "code": "C54129",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Comparator",
          "instanceType": "Code"
        },
        "role": {
          "id": "5395e749-1ccf-415f-8c8f-383236f5dfde",
          "code": "C54129",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Comparator",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Physician's choice chemotherapy",
        "productIds": [
          "prod_2"
        ],
        "administrationIds": [
          "admin_2"
        ]
      },
      {
        "id": "int_3",
        "name": "Docetaxel",
        "type": {
          "id": "0465b626-3155-4d8f-8662-94647f5016a1",
          "code": "C54129",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Comparator",
          "instanceType": "Code"
        },
        "role": {
          "id": "68a7d37c-7217-41ae-b876-074d9aef2468",
          "code": "C54129",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Comparator",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Physician's choice chemotherapy",
        "productIds": [
          "prod_3"
        ],
        "administrationIds": [
          "admin_3"
        ]
      },
      {
        "id": "int_4",
        "name": "Irinotecan",
        "type": {
          "id": "f6ddae42-af1a-46aa-a1a0-443e6337fe9d",
          "code": "C54129",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Comparator",
          "instanceType": "Code"
        },
        "role": {
          "id": "c6240f53-5916-4f88-9004-6a44d3b3052f",
          "code": "C54129",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Comparator",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Physician's choice chemotherapy",
        "productIds": [
          "prod_4"
        ],
        "administrationIds": [
          "admin_4"
        ]
      },
      {
        "id": "int_5",
        "name": "Corticosteroids",
        "type": {
          "id": "09edb68e-2691-418c-adcf-43c5fab3ea5e",
          "code": "C54125",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Rescue Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "ccce3603-4b85-4e9e-a9fa-a0d5b62f3e7b",
          "code": "C54125",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Rescue Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Used for management of immune-related adverse events and as premedication for chemotherapy"
      },
      {
        "id": "int_6",
        "name": "Antihistamines",
        "type": {
          "id": "03ec8530-f9d3-4911-a894-1c0e0735a1de",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "6aca00b9-8179-4b3f-9767-0551abbbb780",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted for infusion reaction management and chemotherapy premedication"
      },
      {
        "id": "int_7",
        "name": "Antineoplastic systemic chemotherapy",
        "type": {
          "id": "a73b8470-5008-48b5-bea3-00d3b907d895",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "0d003a21-ed77-47c2-a605-06c7e7690106",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Prohibited during screening and treatment phase unless specified in protocol"
      },
      {
        "id": "int_8",
        "name": "Live vaccines",
        "type": {
          "id": "9cb653ce-adc7-4ea5-a842-f683c2304980",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "945deb5e-a0c6-40bd-9e60-0acb9dd08bbc",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Prohibited within 30 days prior to first dose and during trial for pembrolizumab arm"
      }
    ],
    "administrableProducts": [
      {
        "id": "prod_1",
        "name": "Pembrolizumab",
        "administrableDoseForm": {
          "id": "f8c86058-117b-47f4-af84-c48e74273b9f",
          "code": "C42945",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Injection",
          "standardCode": {
            "id": "5dc0ab20-b215-4896-b436-66e241931c74",
            "code": "C42945",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Injection",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "5e7729b9-b00c-49d5-9a85-6ba1b0a047c6",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "Not specified in provided text",
        "substanceIds": [
          "sub_1"
        ],
        "manufacturer": "Merck Sharp & Dohme Corp."
      },
      {
        "id": "prod_2",
        "name": "Paclitaxel",
        "administrableDoseForm": {
          "id": "c6ecd6ae-1f06-428c-8678-46853fe31d32",
          "code": "C42945",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Injection",
          "standardCode": {
            "id": "108db1dd-1810-40bf-bcb0-ac9239d10d54",
            "code": "C42945",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Injection",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "55688256-d596-4fdf-bb91-365d6b2bc36c",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "Not specified in provided text",
        "substanceIds": [
          "sub_2"
        ],
        "manufacturer": "Not specified"
      },
      {
        "id": "prod_3",
        "name": "Docetaxel",
        "administrableDoseForm": {
          "id": "2a6f3d58-6af3-409f-bc2b-553223b89e81",
          "code": "C42945",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Injection",
          "standardCode": {
            "id": "d8632bb3-b90a-4415-a432-6fd837d379b6",
            "code": "C42945",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Injection",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "6bdac282-e664-49be-855b-6626484545f1",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "Not specified in provided text",
        "substanceIds": [
          "sub_3"
        ],
        "manufacturer": "Not specified"
      },
      {
        "id": "prod_4",
        "name": "Irinotecan",
        "administrableDoseForm": {
          "id": "4f347a08-9304-402a-b671-946c9bc77e41",
          "code": "C42945",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Injection",
          "standardCode": {
            "id": "2ccd73b6-2c89-415c-a531-67eebb033b7e",
            "code": "C42945",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Injection",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "49aadf77-9071-44af-8631-77f16d5bafae",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "Not specified in provided text",
        "substanceIds": [
          "sub_4"
        ],
        "manufacturer": "Not specified"
      }
    ],
    "administrations": [
      {
        "id": "admin_1",
        "name": "Pembrolizumab Regimen",
        "instanceType": "Administration",
        "dose": "200 mg",
        "doseFrequency": "Every 3 weeks",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "Until disease progression, unacceptable toxicity, or 35 administrations (approx. 2 years)"
      },
      {
        "id": "admin_2",
        "name": "Paclitaxel Regimen",
        "instanceType": "Administration",
        "dose": "80-100 mg/m2",
        "doseFrequency": "Days 1, 8, and 15 of every 28-day cycle",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "Until disease progression or unacceptable toxicity"
      },
      {
        "id": "admin_3",
        "name": "Docetaxel Regimen",
        "instanceType": "Administration",
        "dose": "75 mg/m2",
        "doseFrequency": "Day 1 of every 21-day cycle",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "Until disease progression or unacceptable toxicity"
      },
      {
        "id": "admin_4",
        "name": "Irinotecan Regimen",
        "instanceType": "Administration",
        "dose": "180 mg/m2",
        "doseFrequency": "Day 1 of every 14-day cycle",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "Until disease progression or unacceptable toxicity"
      }
    ],
    "substances": [
      {
        "id": "sub_1",
        "name": "Pembrolizumab",
        "instanceType": "Substance",
        "description": "Humanized monoclonal antibody against PD-1"
      },
      {
        "id": "sub_2",
        "name": "Paclitaxel",
        "instanceType": "Substance",
        "description": "Taxane antineoplastic agent"
      },
      {
        "id": "sub_3",
        "name": "Docetaxel",
        "instanceType": "Substance",
        "description": "Taxane antineoplastic agent"
      },
      {
        "id": "sub_4",
        "name": "Irinotecan",
        "instanceType": "Substance",
        "description": "Topoisomerase I inhibitor"
      }
    ],
    "medicalDevices": [],
    "summary": {
      "interventionCount": 8,
      "productCount": 4,
      "deviceCount": 0
    }
  },
  "rawResponse": {
    "interventions": [
      {
        "name": "Pembrolizumab (MK-3475)",
        "role": "Investigational Product",
        "description": "Anti-PD-1 monoclonal antibody for advanced/metastatic esophageal cancer"
      },
      {
        "name": "Paclitaxel",
        "role": "Comparator",
        "description": "Physician's choice chemotherapy"
      },
      {
        "name": "Docetaxel",
        "role": "Comparator",
        "description": "Physician's choice chemotherapy"
      },
      {
        "name": "Irinotecan",
        "role": "Comparator",
        "description": "Physician's choice chemotherapy"
      },
      {
        "name": "Corticosteroids",
        "role": "Rescue Medication",
        "description": "Used for management of immune-related adverse events and as premedication for chemotherapy"
      },
      {
        "name": "Antihistamines",
        "role": "Concomitant Medication",
        "description": "Permitted for infusion reaction management and chemotherapy premedication"
      },
      {
        "name": "Antineoplastic systemic chemotherapy",
        "role": "Concomitant Medication",
        "description": "Prohibited during screening and treatment phase unless specified in protocol"
      },
      {
        "name": "Live vaccines",
        "role": "Concomitant Medication",
        "description": "Prohibited within 30 days prior to first dose and during trial for pembrolizumab arm"
      }
    ],
    "products": [
      {
        "name": "Pembrolizumab",
        "doseForm": "Injection",
        "strength": "Not specified in provided text",
        "manufacturer": "Merck Sharp & Dohme Corp."
      },
      {
        "name": "Paclitaxel",
        "doseForm": "Injection",
        "strength": "Not specified in provided text",
        "manufacturer": "Not specified"
      },
      {
        "name": "Docetaxel",
        "doseForm": "Injection",
        "strength": "Not specified in provided text",
        "manufacturer": "Not specified"
      },
      {
        "name": "Irinotecan",
        "doseForm": "Injection",
        "strength": "Not specified in provided text",
        "manufacturer": "Not specified"
      }
    ],
    "substances": [
      {
        "name": "Pembrolizumab",
        "description": "Humanized monoclonal antibody against PD-1"
      },
      {
        "name": "Paclitaxel",
        "description": "Taxane antineoplastic agent"
      },
      {
        "name": "Docetaxel",
        "description": "Taxane antineoplastic agent"
      },
      {
        "name": "Irinotecan",
        "description": "Topoisomerase I inhibitor"
      }
    ],
    "administrations": [
      {
        "name": "Pembrolizumab Regimen",
        "dose": "200 mg",
        "frequency": "Every 3 weeks",
        "route": "Intravenous",
        "duration": "Until disease progression, unacceptable toxicity, or 35 administrations (approx. 2 years)"
      },
      {
        "name": "Paclitaxel Regimen",
        "dose": "80-100 mg/m2",
        "frequency": "Days 1, 8, and 15 of every 28-day cycle",
        "route": "Intravenous",
        "duration": "Until disease progression or unacceptable toxicity"
      },
      {
        "name": "Docetaxel Regimen",
        "dose": "75 mg/m2",
        "frequency": "Day 1 of every 21-day cycle",
        "route": "Intravenous",
        "duration": "Until disease progression or unacceptable toxicity"
      },
      {
        "name": "Irinotecan Regimen",
        "dose": "180 mg/m2",
        "frequency": "Day 1 of every 14-day cycle",
        "route": "Intravenous",
        "duration": "Until disease progression or unacceptable toxicity"
      }
    ],
    "devices": []
  }
}